Ensign Peak Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$222K Hold
6,570
﹤0.01% 1267
2025
Q4
$179K Sell
6,570
-6,050
-48% -$212K ﹤0.01% 1360
2025
Q3
$507K Sell
12,620
-12,350
-49% -$465K ﹤0.01% 1380
2025
Q2
$831K Sell
24,970
-6,950
-22% -$211K ﹤0.01% 1353
2025
Q1
$935K Hold
31,920
﹤0.01% 1293
2024
Q4
$1.05M Hold
31,920
﹤0.01% 1294
2024
Q3
$1.42M Hold
31,920
﹤0.01% 1120
2024
Q2
$1.38M Hold
31,920
﹤0.01% 1082
2024
Q1
$933K Sell
31,920
-1,610
-5% -$43.1K ﹤0.01% 1376
2023
Q4
$747K Hold
33,530
﹤0.01% 1535
2023
Q3
$830K Hold
33,530
﹤0.01% 1340
2023
Q2
$950K Hold
33,530
﹤0.01% 1305
2023
Q1
$770K Hold
33,530
﹤0.01% 1444
2022
Q4
$942K Buy
33,530
+21,100
+170% +$595K ﹤0.01% 1209
2022
Q3
$352K Buy
12,430
+250
+2% +$6.71K ﹤0.01% 1633
2022
Q2
$270K Hold
12,180
﹤0.01% 1710
2022
Q1
$355K Hold
12,180
﹤0.01% 1692
2021
Q4
$400K Buy
+12,180
New +$490K ﹤0.01% 1702

Other funds holding AGIO